Kopran Limited — Investor Meet, 27-03-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Kopran Limited has announced a board meeting on March 20, 2025, to discuss the proposed merger of Kopran Laboratories with Kopran Limited. The share exchange ratio is set at 100 fully paid equity shares of Kopran Limited for every 45 shares of Kopran Laboratories. This merger aims to leverage both companies' strengths and tap into the rapidly growing Indian diagnostics market, projected to reach $25 billion by FY 2028. The merger is anticipated to be EPS accretive, enhancing shareholder value while increasing Kopran's manufacturing capabilities and market presence. Investor sentiment may be positively influenced by this strategic move into the healthcare sector, aligning with industry growth trends.